Radiotracer synthesis platform iMiGiNE

PETrobotic

iMiGiNE is a robotized system capable of producing various radiopharmaceuticals used in PET imaging PET imaging is one of the most powerful and least invasive ways of observing the metabolic activity of an organ and a tumor or any cells in body tissue. Today, the radiopharmaceutical molecule widely used in PET imaging is 18F-FDG (FluoroDeoxyGlucose), which is produced in large-size cyclotrons and distributed by major private centers. Financial and technical constraints limit the use of more than 200 other molecules that could be of clinical interest. Medical and research centers are unable to use more specific molecules, with an often short half-life. This limited access has direct consequences on patient care: less specific radiopharmaceuticals, less adequate treatment. It combines a cyclotron iMiTRACE with a radiochemistry room iMiLAB Superconducting magnet technology, external self-shielded beam Automated target changer Automated syringe dispenser, including high-precision activity measurement and traceability For a few years now, with various collaborators, PMB has been designing and developing a cutting-edge automated system for the production of radiopharmaceuticals used in PET imaging and theranostics. More than just another radiopharmaceutical dispenser, we have envisioned a system designed to improve and optimize patient care, while providing new grounds to further research in the medical imaging field. Compact and fully robotized, it offers an alternative to the heavy traditional radiopharmaceutical production processes and grants imaging centers access to a variety of molecules, at a low cost.